chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Basophil count normal, Basophil percentage decreased, Dizziness, Dysphagia
Clinical narrative: Initial symptoms (11/27/2021): 1. Urticaria on scalp, ears, neck, arms, chest, back, stomach, legs, genitals, perianal area, hands, and feet. 2. Arthralgia in arms, hands, and feet. 3. Pain 6/10. 4. Edema of feet and hands.  Initial treatment (11/27/2021): Diphenhydramine q 4 and 20 mg prednisone per day for 4 days.  Pain, edema, and arthralgia worsened on 11/28/2021. Updated treatment (11/28/2021): Prednisone 60 mg per day for 4 days, then 40 mg per day for 4 days, then 20 mg per day for 4 days, then 10 mg per day for 4 days. Betamethasone ointment to be used sparingly on most painful areas. Diphenhydramine, Famotidine, and Cetirizine daily or as needed. December 1 symptoms: Urticaria mostly resolved, edema resolved, pain improved, arthralgia in arms persists, and the onset of difficulty swallowing, dizziness, lightheadedness, and mild altered mental status. December 10 symptoms: Urticaria mostly resolved, edema resolved, arthralgia resolved, difficulty swallowing resolved,  pain resolved, dizziness resolved, lightheadedness resolved, and mild altered mental status mostly resolved.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Eosinophil count normal, Eosinophil percentage, Haematocrit normal, Haemoglobin normal, Immature granulocyte count
Clinical narrative: Initial symptoms (11/27/2021): 1. Urticaria on scalp, ears, neck, arms, chest, back, stomach, legs, genitals, perianal area, hands, and feet. 2. Arthralgia in arms, hands, and feet. 3. Pain 6/10. 4. Edema of feet and hands.  Initial treatment (11/27/2021): Diphenhydramine q 4 and 20 mg prednisone per day for 4 days.  Pain, edema, and arthralgia worsened on 11/28/2021. Updated treatment (11/28/2021): Prednisone 60 mg per day for 4 days, then 40 mg per day for 4 days, then 20 mg per day for 4 days, then 10 mg per day for 4 days. Betamethasone ointment to be used sparingly on most painful areas. Diphenhydramine, Famotidine, and Cetirizine daily or as needed. December 1 symptoms: Urticaria mostly resolved, edema resolved, pain improved, arthralgia in arms persists, and the onset of difficulty swallowing, dizziness, lightheadedness, and mild altered mental status. December 10 symptoms: Urticaria mostly resolved, edema resolved, arthralgia resolved, difficulty swallowing resolved,  pain resolved, dizziness resolved, lightheadedness resolved, and mild altered mental status mostly resolved.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Lymphocyte count increased, Lymphocyte percentage, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal
Clinical narrative: Initial symptoms (11/27/2021): 1. Urticaria on scalp, ears, neck, arms, chest, back, stomach, legs, genitals, perianal area, hands, and feet. 2. Arthralgia in arms, hands, and feet. 3. Pain 6/10. 4. Edema of feet and hands.  Initial treatment (11/27/2021): Diphenhydramine q 4 and 20 mg prednisone per day for 4 days.  Pain, edema, and arthralgia worsened on 11/28/2021. Updated treatment (11/28/2021): Prednisone 60 mg per day for 4 days, then 40 mg per day for 4 days, then 20 mg per day for 4 days, then 10 mg per day for 4 days. Betamethasone ointment to be used sparingly on most painful areas. Diphenhydramine, Famotidine, and Cetirizine daily or as needed. December 1 symptoms: Urticaria mostly resolved, edema resolved, pain improved, arthralgia in arms persists, and the onset of difficulty swallowing, dizziness, lightheadedness, and mild altered mental status. December 10 symptoms: Urticaria mostly resolved, edema resolved, arthralgia resolved, difficulty swallowing resolved,  pain resolved, dizziness resolved, lightheadedness resolved, and mild altered mental status mostly resolved.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Mean cell volume normal, Mental status changes, Monocyte count increased, Monocyte percentage increased, Neutrophil count increased
Clinical narrative: Initial symptoms (11/27/2021): 1. Urticaria on scalp, ears, neck, arms, chest, back, stomach, legs, genitals, perianal area, hands, and feet. 2. Arthralgia in arms, hands, and feet. 3. Pain 6/10. 4. Edema of feet and hands.  Initial treatment (11/27/2021): Diphenhydramine q 4 and 20 mg prednisone per day for 4 days.  Pain, edema, and arthralgia worsened on 11/28/2021. Updated treatment (11/28/2021): Prednisone 60 mg per day for 4 days, then 40 mg per day for 4 days, then 20 mg per day for 4 days, then 10 mg per day for 4 days. Betamethasone ointment to be used sparingly on most painful areas. Diphenhydramine, Famotidine, and Cetirizine daily or as needed. December 1 symptoms: Urticaria mostly resolved, edema resolved, pain improved, arthralgia in arms persists, and the onset of difficulty swallowing, dizziness, lightheadedness, and mild altered mental status. December 10 symptoms: Urticaria mostly resolved, edema resolved, arthralgia resolved, difficulty swallowing resolved,  pain resolved, dizziness resolved, lightheadedness resolved, and mild altered mental status mostly resolved.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Neutrophil percentage, Nucleated red cells, Oedema peripheral, Pain, Platelet count normal
Clinical narrative: Initial symptoms (11/27/2021): 1. Urticaria on scalp, ears, neck, arms, chest, back, stomach, legs, genitals, perianal area, hands, and feet. 2. Arthralgia in arms, hands, and feet. 3. Pain 6/10. 4. Edema of feet and hands.  Initial treatment (11/27/2021): Diphenhydramine q 4 and 20 mg prednisone per day for 4 days.  Pain, edema, and arthralgia worsened on 11/28/2021. Updated treatment (11/28/2021): Prednisone 60 mg per day for 4 days, then 40 mg per day for 4 days, then 20 mg per day for 4 days, then 10 mg per day for 4 days. Betamethasone ointment to be used sparingly on most painful areas. Diphenhydramine, Famotidine, and Cetirizine daily or as needed. December 1 symptoms: Urticaria mostly resolved, edema resolved, pain improved, arthralgia in arms persists, and the onset of difficulty swallowing, dizziness, lightheadedness, and mild altered mental status. December 10 symptoms: Urticaria mostly resolved, edema resolved, arthralgia resolved, difficulty swallowing resolved,  pain resolved, dizziness resolved, lightheadedness resolved, and mild altered mental status mostly resolved.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cell count normal, Red blood cell sedimentation rate normal, Red cell distribution width normal, Urticaria, White blood cell count increased
Clinical narrative: Initial symptoms (11/27/2021): 1. Urticaria on scalp, ears, neck, arms, chest, back, stomach, legs, genitals, perianal area, hands, and feet. 2. Arthralgia in arms, hands, and feet. 3. Pain 6/10. 4. Edema of feet and hands.  Initial treatment (11/27/2021): Diphenhydramine q 4 and 20 mg prednisone per day for 4 days.  Pain, edema, and arthralgia worsened on 11/28/2021. Updated treatment (11/28/2021): Prednisone 60 mg per day for 4 days, then 40 mg per day for 4 days, then 20 mg per day for 4 days, then 10 mg per day for 4 days. Betamethasone ointment to be used sparingly on most painful areas. Diphenhydramine, Famotidine, and Cetirizine daily or as needed. December 1 symptoms: Urticaria mostly resolved, edema resolved, pain improved, arthralgia in arms persists, and the onset of difficulty swallowing, dizziness, lightheadedness, and mild altered mental status. December 10 symptoms: Urticaria mostly resolved, edema resolved, arthralgia resolved, difficulty swallowing resolved,  pain resolved, dizziness resolved, lightheadedness resolved, and mild altered mental status mostly resolved.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Blood test normal, Computerised tomogram head normal, Feeling abnormal, Headache
Clinical narrative: After the Pfizer Covid-19 booster shot (administered November 19, 2021), I experienced a severe headache in the left rear of my head (including behind the ear), an increasing unbalanced/foggy feeling and vision impairment. These symptoms began November 20, 2021 and are increasing in severity, and new symptoms are occurring. On November 25, 2021, my headache was so severe that I became nauseated and had to lie down to try to alleviate the pain. I am currently experiencing the following increasing symptoms: headache, vision issues, imbalance, feeling like I'm "in a fog" and weakness/numbness in my left arm and leg.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hemiparesis, Hypoaesthesia, Magnetic resonance imaging head normal, Muscular weakness, Nausea
Clinical narrative: After the Pfizer Covid-19 booster shot (administered November 19, 2021), I experienced a severe headache in the left rear of my head (including behind the ear), an increasing unbalanced/foggy feeling and vision impairment. These symptoms began November 20, 2021 and are increasing in severity, and new symptoms are occurring. On November 25, 2021, my headache was so severe that I became nauseated and had to lie down to try to alleviate the pain. I am currently experiencing the following increasing symptoms: headache, vision issues, imbalance, feeling like I'm "in a fog" and weakness/numbness in my left arm and leg.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound Doppler normal, Visual impairment
Clinical narrative: After the Pfizer Covid-19 booster shot (administered November 19, 2021), I experienced a severe headache in the left rear of my head (including behind the ear), an increasing unbalanced/foggy feeling and vision impairment. These symptoms began November 20, 2021 and are increasing in severity, and new symptoms are occurring. On November 25, 2021, my headache was so severe that I became nauseated and had to lie down to try to alleviate the pain. I am currently experiencing the following increasing symptoms: headache, vision issues, imbalance, feeling like I'm "in a fog" and weakness/numbness in my left arm and leg.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: After vaccine I got a rash on different spots on my body. It went away. Then I got my second vaccine dose, 1/29/21 and rash came back again. It has been coming back and going away and still I have it right now. I'm afraid to tale a booster now. I use cocoa butter to get rid of it.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram, Back pain, Cardiac stress test, Chest discomfort, Dyspnoea
Clinical narrative: chest tightness, dyspnea on exertion, fatigue, back pain
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Echocardiogram normal, Fatigue, Fibrin D dimer increased
Clinical narrative: chest tightness, dyspnea on exertion, fatigue, back pain
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Patient came in to get the second dose of Moderna vaccine. That dose is 0.5ml, in error the patient was given the Moderna Booster dose which is 0.25ml. According to CDC Administration Errors Revaccination Guidance patient must receive a repeat dose. Patient will be given repeat dose of 0.5ml.
Age: 5.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Patient received a dose of Pfizer COVID-19 Vaccine  Peds formulation (5-11yr) that may have been reconstituted with a single use vial of 0.9%NS that was entered into multiple times to reconstitute other vials of Pfizer vaccine. Staff did not realize the 10mL vial was for single use only (to take out 1.3mL then discard). Each time the vial was used it was swabbed with alcohol and a new syringe was used to enter the vial then to add the diluent to the Pfizer vaccine for reconstitution. The 10mL, 0.9%NS vial was disposed of at the end of each day. The patient did not experience any adverse reaction. At the recommendation of Pfizer and the agency, due to lack of stability data, it was advised to revaccinate the patient.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Blood creatinine increased, Blood urea increased, COVID-19, Chest X-ray abnormal, Cognitive disorder
Clinical narrative: This is a 77y.o. female with hx of +COVID-19, DM2, CKD stage 3, and respiratory failure with hypoxia who presents to by way of EMS, with a chief complaint of SOB. Per EMS, upon their arrival, pt's pulse ox was low 80s and she was placed on a nonrebreather. Currently pt is on 5L O2 saturating at 98%. She is AOx1, oriented to her name and presence in a hospital, unable to specify hospital name or reason for being here. Pt admits SOB, denies chest pain, abd pain, or HA.    Pt's daughter sitting at bedside notes taking the pt to 10 days ago for cough and fatigue. At that time she was dx'd with covid and sent home to quarantine. Over the next week her cough and fatigue worsened. Her daughter states the pt was found sitting in her own urine for 2 days and not coherent so she decided to call EMS. Per daughter, pt does not drink alcohol, smoke or use tobacco products or recreational drugs, and is not on O2 at home. Baseline is AOx3. Pt is full code.   Upon arrival to the ED:  o Vitals: T 97.3°F, BP 112/56, HR92, RR 18, SpO2 98% on RA.  o EKG demonstrates NSR with increased T wave amplitude in the anterolateral leads o Lab work obtained and remarkable for:  ? CBC: thrombocytosis (552) ? BMP: elevated BUN (79), Crt (1.93), decreased GFR (28) ? Trops: 0.04 and 0.03 o Imaging demonstrates:             CXR: multifocal pneumonia in the mid-lower portions of both lungs concerning for covid-PNA             Head CT: no acute intracranial process o Patient given decadron, azithromycin, rocephin o ID has been consulted
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram head normal, Condition aggravated, Cough, Dyspnoea, Electrocardiogram T wave amplitude increased
Clinical narrative: This is a 77y.o. female with hx of +COVID-19, DM2, CKD stage 3, and respiratory failure with hypoxia who presents to by way of EMS, with a chief complaint of SOB. Per EMS, upon their arrival, pt's pulse ox was low 80s and she was placed on a nonrebreather. Currently pt is on 5L O2 saturating at 98%. She is AOx1, oriented to her name and presence in a hospital, unable to specify hospital name or reason for being here. Pt admits SOB, denies chest pain, abd pain, or HA.    Pt's daughter sitting at bedside notes taking the pt to 10 days ago for cough and fatigue. At that time she was dx'd with covid and sent home to quarantine. Over the next week her cough and fatigue worsened. Her daughter states the pt was found sitting in her own urine for 2 days and not coherent so she decided to call EMS. Per daughter, pt does not drink alcohol, smoke or use tobacco products or recreational drugs, and is not on O2 at home. Baseline is AOx3. Pt is full code.   Upon arrival to the ED:  o Vitals: T 97.3°F, BP 112/56, HR92, RR 18, SpO2 98% on RA.  o EKG demonstrates NSR with increased T wave amplitude in the anterolateral leads o Lab work obtained and remarkable for:  ? CBC: thrombocytosis (552) ? BMP: elevated BUN (79), Crt (1.93), decreased GFR (28) ? Trops: 0.04 and 0.03 o Imaging demonstrates:             CXR: multifocal pneumonia in the mid-lower portions of both lungs concerning for covid-PNA             Head CT: no acute intracranial process o Patient given decadron, azithromycin, rocephin o ID has been consulted
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Full blood count abnormal, Glomerular filtration rate decreased, Incoherent, Metabolic function test abnormal
Clinical narrative: This is a 77y.o. female with hx of +COVID-19, DM2, CKD stage 3, and respiratory failure with hypoxia who presents to by way of EMS, with a chief complaint of SOB. Per EMS, upon their arrival, pt's pulse ox was low 80s and she was placed on a nonrebreather. Currently pt is on 5L O2 saturating at 98%. She is AOx1, oriented to her name and presence in a hospital, unable to specify hospital name or reason for being here. Pt admits SOB, denies chest pain, abd pain, or HA.    Pt's daughter sitting at bedside notes taking the pt to 10 days ago for cough and fatigue. At that time she was dx'd with covid and sent home to quarantine. Over the next week her cough and fatigue worsened. Her daughter states the pt was found sitting in her own urine for 2 days and not coherent so she decided to call EMS. Per daughter, pt does not drink alcohol, smoke or use tobacco products or recreational drugs, and is not on O2 at home. Baseline is AOx3. Pt is full code.   Upon arrival to the ED:  o Vitals: T 97.3°F, BP 112/56, HR92, RR 18, SpO2 98% on RA.  o EKG demonstrates NSR with increased T wave amplitude in the anterolateral leads o Lab work obtained and remarkable for:  ? CBC: thrombocytosis (552) ? BMP: elevated BUN (79), Crt (1.93), decreased GFR (28) ? Trops: 0.04 and 0.03 o Imaging demonstrates:             CXR: multifocal pneumonia in the mid-lower portions of both lungs concerning for covid-PNA             Head CT: no acute intracranial process o Patient given decadron, azithromycin, rocephin o ID has been consulted
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumonia, Sinus rhythm, Thrombocytosis, Troponin, Urinary incontinence
Clinical narrative: This is a 77y.o. female with hx of +COVID-19, DM2, CKD stage 3, and respiratory failure with hypoxia who presents to by way of EMS, with a chief complaint of SOB. Per EMS, upon their arrival, pt's pulse ox was low 80s and she was placed on a nonrebreather. Currently pt is on 5L O2 saturating at 98%. She is AOx1, oriented to her name and presence in a hospital, unable to specify hospital name or reason for being here. Pt admits SOB, denies chest pain, abd pain, or HA.    Pt's daughter sitting at bedside notes taking the pt to 10 days ago for cough and fatigue. At that time she was dx'd with covid and sent home to quarantine. Over the next week her cough and fatigue worsened. Her daughter states the pt was found sitting in her own urine for 2 days and not coherent so she decided to call EMS. Per daughter, pt does not drink alcohol, smoke or use tobacco products or recreational drugs, and is not on O2 at home. Baseline is AOx3. Pt is full code.   Upon arrival to the ED:  o Vitals: T 97.3°F, BP 112/56, HR92, RR 18, SpO2 98% on RA.  o EKG demonstrates NSR with increased T wave amplitude in the anterolateral leads o Lab work obtained and remarkable for:  ? CBC: thrombocytosis (552) ? BMP: elevated BUN (79), Crt (1.93), decreased GFR (28) ? Trops: 0.04 and 0.03 o Imaging demonstrates:             CXR: multifocal pneumonia in the mid-lower portions of both lungs concerning for covid-PNA             Head CT: no acute intracranial process o Patient given decadron, azithromycin, rocephin o ID has been consulted
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Fear, Mobility decreased, Oedema peripheral
Clinical narrative: On 03/07/2021, a couple of days after I got the shot I experienced axillary swelling under my armpit, round, ball-like, on the same side the shot was administered. I could not put my arm all the way down because it was protruding under my armpit. Like someone put a tennis ball under my armpit. I saw a doctor as soon as the issue occurred. They told me to take anti-inflammatories, like Advil or Aleve. They also said it was an immune response. That my body was trying to tolerate the vaccine. They said it was not anything to be concerned about at that moment. It just seemed scary. It resolved after a few days.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: severe swelling under my armpit for the past two days from the time i received the shot
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient was erroneously given their 2nd dose too early.  That patient's first dose was on 11/29/21.  The patient did sit for 15 minutes after the vaccine was administered and experienced no adverse reaction.  The patient was alerted and told that per Pfizer's Medical Information regarding invalid dosing, she should return for a 3rd dose 21 days after today's invalid dose, 12/10/21.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product administration error
Clinical narrative: Patient was given the >12year old product instead of the 5-11 year old product.   Error was recognized after the vaccine was administered when healthcare professional went to document.  Pharmacist that was contacted, recommended to keep child in office and observe for at least 30 minutes.  Advised that likelihood of side effects common but harm not likely.  Advised to treat any fever or symptoms to treat with acetaminophen or ibuprofen. Patient left the office after 30 minutes. No further issues reported.
Age: 71.0
Sex: F
Vaccine: FLU4
Symptoms: Full blood count, Gene mutation identification test, Laboratory test abnormal, Mobility decreased, Myalgia
Clinical narrative: 3am the night after receiving the vaccine, awoke to intense pain and limited mobility in legs. Subsequent muscle pain over entire body over the period of several weeks.  Diagnosed Polymyalgia Rheumatica  after lab testing, evaluation.
Age: 71.0
Sex: F
Vaccine: FLU4
Symptoms: Pain, Polymyalgia rheumatica, Red blood cell sedimentation rate
Clinical narrative: 3am the night after receiving the vaccine, awoke to intense pain and limited mobility in legs. Subsequent muscle pain over entire body over the period of several weeks.  Diagnosed Polymyalgia Rheumatica  after lab testing, evaluation.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever began the first evening and climbed to 104.5 (taken with forehead scanner)  by the next day even with having taken Tylenol.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Systemic: Allergic: Rash Generalized-Medium.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: "Moderna COVID-19 vaccine EUA" Patient received 0.5ml instead of 0.25ml COVID booster dose.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Patient admitted for progressive SOA, found to be COVID +.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Anxiety, Arthralgia, Autonomic nervous system imbalance, Back pain
Clinical narrative: POTS MCAS Neuropathy  Dysautonomia  Muscle Pain Insomnia GI Distress Phantosmia  Blood Clotting Shortness of breath Body temp disregulation  Headaches  Rosacea  Chest pain  Back pain Light headed  Fatigue  Brain fog and cognitive impairment  Eye dryness Rashes  Joint pain Anxiety
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature abnormal, Chest pain, Cognitive disorder, Dizziness, Dry eye
Clinical narrative: POTS MCAS Neuropathy  Dysautonomia  Muscle Pain Insomnia GI Distress Phantosmia  Blood Clotting Shortness of breath Body temp disregulation  Headaches  Rosacea  Chest pain  Back pain Light headed  Fatigue  Brain fog and cognitive impairment  Eye dryness Rashes  Joint pain Anxiety
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Feeling abnormal, Headache, Insomnia
Clinical narrative: POTS MCAS Neuropathy  Dysautonomia  Muscle Pain Insomnia GI Distress Phantosmia  Blood Clotting Shortness of breath Body temp disregulation  Headaches  Rosacea  Chest pain  Back pain Light headed  Fatigue  Brain fog and cognitive impairment  Eye dryness Rashes  Joint pain Anxiety
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test, Mast cell activation syndrome, Myalgia, Neuropathy peripheral, Parosmia
Clinical narrative: POTS MCAS Neuropathy  Dysautonomia  Muscle Pain Insomnia GI Distress Phantosmia  Blood Clotting Shortness of breath Body temp disregulation  Headaches  Rosacea  Chest pain  Back pain Light headed  Fatigue  Brain fog and cognitive impairment  Eye dryness Rashes  Joint pain Anxiety
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Postural orthostatic tachycardia syndrome, Rash, Rosacea, Thrombosis
Clinical narrative: POTS MCAS Neuropathy  Dysautonomia  Muscle Pain Insomnia GI Distress Phantosmia  Blood Clotting Shortness of breath Body temp disregulation  Headaches  Rosacea  Chest pain  Back pain Light headed  Fatigue  Brain fog and cognitive impairment  Eye dryness Rashes  Joint pain Anxiety
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: ** Medication error WITHOUT adverse drug reaction.   A 12-year-old patient came in for their 1st dose. Received the 5-11yr Pfizer dose (10mcg/0.2mL) instead of 12 yrs and older Pfizer dose (30mccg/0.3mL).   Followed recommendation from the CDC Administration Errors and Deviations and Pfizer medical line: If a patient between 12-17 got 5-11 yrs formulation (10mcg/0.2mL) as the first dose, do not repeat dose. Instead, administer the 12yrs and older formulation (30mcg/0.3mL) 21 days after the last dose to complete the primary series.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood creatinine increased, Blood magnesium, COVID-19, Chills
Clinical narrative: Nausea, Vomiting, Diarrhea      Fever/body aches for 1 week. Tested negative for covid. Continues to have N/V/D with weight loss. She had a kidney transplant.  ? Fever     HPI patient is a 58-year-old female presents to ED for nausea vomiting diarrhea. Patient has a history of chronic kidney disease with a kidney transplant 10 years prior, hypertension, hyperlipidemia, and polycystic liver disease. Patient reports that she's had nausea and vomiting and diarrhea for one week. Patient continues to have worsening symptoms. Patient has had weight loss. Patient was recently tested for COVID which was negative. Patient reports fatigue and feeling weak and dizzy. Patient is unable to tolerate oral intake due to the nausea and vomiting. Patient denies any other complaints including chest pain, shortness of breath, cough, numbness or tingling.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Fatigue, Full blood count abnormal, Glomerular filtration rate decreased
Clinical narrative: Nausea, Vomiting, Diarrhea      Fever/body aches for 1 week. Tested negative for covid. Continues to have N/V/D with weight loss. She had a kidney transplant.  ? Fever     HPI patient is a 58-year-old female presents to ED for nausea vomiting diarrhea. Patient has a history of chronic kidney disease with a kidney transplant 10 years prior, hypertension, hyperlipidemia, and polycystic liver disease. Patient reports that she's had nausea and vomiting and diarrhea for one week. Patient continues to have worsening symptoms. Patient has had weight loss. Patient was recently tested for COVID which was negative. Patient reports fatigue and feeling weak and dizzy. Patient is unable to tolerate oral intake due to the nausea and vomiting. Patient denies any other complaints including chest pain, shortness of breath, cough, numbness or tingling.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Hypochloraemia, Hypophagia, Leukopenia, Lymphocyte count decreased, Nausea
Clinical narrative: Nausea, Vomiting, Diarrhea      Fever/body aches for 1 week. Tested negative for covid. Continues to have N/V/D with weight loss. She had a kidney transplant.  ? Fever     HPI patient is a 58-year-old female presents to ED for nausea vomiting diarrhea. Patient has a history of chronic kidney disease with a kidney transplant 10 years prior, hypertension, hyperlipidemia, and polycystic liver disease. Patient reports that she's had nausea and vomiting and diarrhea for one week. Patient continues to have worsening symptoms. Patient has had weight loss. Patient was recently tested for COVID which was negative. Patient reports fatigue and feeling weak and dizzy. Patient is unable to tolerate oral intake due to the nausea and vomiting. Patient denies any other complaints including chest pain, shortness of breath, cough, numbness or tingling.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory viral panel, SARS-CoV-2 test positive, Vomiting, Weight decreased
Clinical narrative: Nausea, Vomiting, Diarrhea      Fever/body aches for 1 week. Tested negative for covid. Continues to have N/V/D with weight loss. She had a kidney transplant.  ? Fever     HPI patient is a 58-year-old female presents to ED for nausea vomiting diarrhea. Patient has a history of chronic kidney disease with a kidney transplant 10 years prior, hypertension, hyperlipidemia, and polycystic liver disease. Patient reports that she's had nausea and vomiting and diarrhea for one week. Patient continues to have worsening symptoms. Patient has had weight loss. Patient was recently tested for COVID which was negative. Patient reports fatigue and feeling weak and dizzy. Patient is unable to tolerate oral intake due to the nausea and vomiting. Patient denies any other complaints including chest pain, shortness of breath, cough, numbness or tingling.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: 11 yo patient received 12+ vaccine after patient's parent wrote they were 12 on the consent form. No adverse event.
Age: 7.0
Sex: M
Vaccine: MNQ, RAB
Symptoms: Injection site discolouration, Injection site erythema, Injection site induration, Skin texture abnormal
Clinical narrative: On 12/9 the mother reported redness around the injection site on the right arm. Upon inspection, the are had a baseball size area of redness around the injection site. The area was mildly discolored, a dusky color behind the redness). The area was very firm and the skin in that area had an altered texture. At 36 hours there seems to be no improvement. Ice packs and Tylenol were recommended. There is not sign of infection, pain, or issues with ROM.
Age: 80.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Product storage error
Clinical narrative: Patient was given expired Janssen booster. Vial was punctured 3 days prior but left in refrigerator. Vial was outside the 6 hour window in refrigerator when dose was administered. Additional dose was given the next day per CDC guidance.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Booster dose was drawn from a Moderna vial that had been at room temperature for 23 hours.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: This patient was provided 0.2 cc of an adult Pfizer vaccine in error. They should have been provided a 0.3 mg dose instead. Staff member previously drew up pediatric Pfizer vaccine, which required different types of reconstitution than the adult Pfizer vaccine. Although, the correct amount of saline was used to dilute the vaccine, the incorrect dose was given to the patient. The staff who drew up the vaccine did not give the patient their vaccine. They should have drawn up the complete amount before providing them to staff for use. These patients were contacted to receive a replace full dose per guidelines.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: "Moderna COVID-19 vaccine," Patient received 0.5ml instead of 0.25ml COVID booster dose.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site pain, Myalgia, Pyrexia
Clinical narrative: Site injection pain, chills, low grade fever, muscle aches for 24 hours.  Treated with over the counter Tylenol and fluids.  This was the booster shot and surprised at reaction given that I had COVID the end of January 2021.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Induration, Pain in extremity, Peripheral swelling
Clinical narrative: Patient reported a bump about the size of a dime that was painful, swollen and hard.  The patient reported that the bump moved to different sites on the arm.  I advised the patient to contact her physician and seek treatment if necessary.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: I walked out in the cold for about an hour, and about 5 mins after coming inside, I broke out in hives on my left leg above the knee. I'm reporting this because according to the RA, urticaria has been reported as a side effect of receiving an mRNA vaccine, and I have never experienced this type of skin reaction in the past.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 2nd dose was given 7 days early
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Booster dose administered was the 21st puncture of Moderna vial.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: Patient came in for the COVID vaccine booster. When in the clinic the patient received a dose at 0.3ml of the vaccine that was undiluted. The correct dose was provided, the wrong concentration was given.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph gland to golf ball size in left armpit noticed 36 hours after booster vaccination given.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Decreased appetite, Diarrhoea, Fatigue, Feeling abnormal
Clinical narrative: I did not notice any major issues during the waiting period after receiving the shot, and conducted another errand afterwards.  While in that building, about an hour and a half after the vaccination, sudden sharp abdominal pain (nearly identical to the few occasions when I have eaten food that was inadvertently contaminated with shellfish or when I have been injected with iodine contrast by negligent technicians) hit me and I rushed to the bathroom.  Pain continued during and after, with moderate diarrhea and foul-odor gas occurring for the remainder of the day.  Extreme fatigue began about 1 pm, and continued for three days (near constant somnolence until Wednesday evening Dec 8th, with one- to two-hour interruptions when I forced myself to remain awake for meals, etc.)  Abdominal pain lessened by 9 pm December 6th, but loss of appetite and nausea continued through 1 pm December 7th.  Realized on December 9th (with abatement of symptom) that my tongue had been partially numb (mild, only on tip) for 3 days.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Flatulence, Hypoaesthesia oral, Nausea
Clinical narrative: I did not notice any major issues during the waiting period after receiving the shot, and conducted another errand afterwards.  While in that building, about an hour and a half after the vaccination, sudden sharp abdominal pain (nearly identical to the few occasions when I have eaten food that was inadvertently contaminated with shellfish or when I have been injected with iodine contrast by negligent technicians) hit me and I rushed to the bathroom.  Pain continued during and after, with moderate diarrhea and foul-odor gas occurring for the remainder of the day.  Extreme fatigue began about 1 pm, and continued for three days (near constant somnolence until Wednesday evening Dec 8th, with one- to two-hour interruptions when I forced myself to remain awake for meals, etc.)  Abdominal pain lessened by 9 pm December 6th, but loss of appetite and nausea continued through 1 pm December 7th.  Realized on December 9th (with abatement of symptom) that my tongue had been partially numb (mild, only on tip) for 3 days.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary, Death, Laboratory test, Pyrexia, Respiratory failure
Clinical narrative: Fever within 16.5 hours of vaccine administration followed by progressive hypoxemic respiratory failure and death on 12/10/2021 at 014o
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: This patient was provided 0.2 cc of an adult Pfizer vaccine in error, as they should have been provided a 0.3 mg dose instead.    Staff member was previously drawing up pediatric Pfizer vaccine which requires different types of re-constitution than the adult Pfizer vaccine. While the correct amount of saline was used to dilute the vaccine, the incorrect drawn up dose was given to the patient.   Patient has been contacted and scheduled to receive appropriate replacement dose.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus, Vertigo
Clinical narrative: Tinnitus and vertigo
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: shortness of breath, hypoxia since around 12/7/21
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Asthenia, COVID-19, COVID-19 pneumonia, Cough
Clinical narrative: This is a 70y.o.female with a history of hypertension, hyperlipidemia, diabetes, previous stroke, atrial fibrillation who presents secondary to weakness, abdominal pain, nausea, and vomiting. Her symptoms have been progressively worsening over the past couple of days. She also reports a dry cough. She is unable to tolerate oral intake secondary to vomiting. States she is vaccinated for COVID 19 Found to have fever of 100.2  Tachycardic with heart rates in the 100s.  COVID 19 positive. Abdominal x-ray, chest x-ray, UA, blood cultures are all pending Started on IV fluids.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Hypophagia, Nausea, Pyrexia, SARS-CoV-2 test positive, Tachycardia
Clinical narrative: This is a 70y.o.female with a history of hypertension, hyperlipidemia, diabetes, previous stroke, atrial fibrillation who presents secondary to weakness, abdominal pain, nausea, and vomiting. Her symptoms have been progressively worsening over the past couple of days. She also reports a dry cough. She is unable to tolerate oral intake secondary to vomiting. States she is vaccinated for COVID 19 Found to have fever of 100.2  Tachycardic with heart rates in the 100s.  COVID 19 positive. Abdominal x-ray, chest x-ray, UA, blood cultures are all pending Started on IV fluids.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: This is a 70y.o.female with a history of hypertension, hyperlipidemia, diabetes, previous stroke, atrial fibrillation who presents secondary to weakness, abdominal pain, nausea, and vomiting. Her symptoms have been progressively worsening over the past couple of days. She also reports a dry cough. She is unable to tolerate oral intake secondary to vomiting. States she is vaccinated for COVID 19 Found to have fever of 100.2  Tachycardic with heart rates in the 100s.  COVID 19 positive. Abdominal x-ray, chest x-ray, UA, blood cultures are all pending Started on IV fluids.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Eye swelling, Inflammation, Lymphadenopathy, Ocular hyperaemia
Clinical narrative: Patient noticed some changes to his eye two days after receiving the Pfizer booster vaccine. He also received his flu shot at the same time. Symptoms included swollen red eye, and swollen lymph node on right arm. He was seen by an ophthalmologist and placed on a steroid. MD believes it was an inflammatory response to the vaccine as he has seen similar responses.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Pain, Peripheral swelling, Pruritus
Clinical narrative: Exactly seven days after the shot I woke up with a very swollen arm from my elbow to my shoulder it was very swollen, itchy, and hot. I just used cold compresses to help with the itching and hotness and swelling. I also took Tylenol to help with the pain.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site warmth
Clinical narrative: I have "covid arm" or "Moderna Arm" after thr Moderna Booster vaccine. My upper arm has  a large red oval region(around the injection site but basically cover most of my upper arm) that is painful, itchy, and hot to the touch. Noticed the redness when I looked at my arm two days after the booster. However, I felt the pain and itchy skin and hotness from day one, so the redness may have started the first night. I first looked at it and noticed the redness the morning of day 3.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Gait disturbance, Magnetic resonance imaging
Clinical narrative: On 10/15/2021, I started to have serve pain in my lower back, that completely crippled me to where I could barely walk. This lasted for about two days. Since then, I have repeated off and on of the same symptoms, once a week.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 2nd dose given 7 days early
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: "Moderna COVID-19 vaccine EUA" Patient received 0.5ml instead of 0.25ml COVID booster dose.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy, Headache, Pain in extremity
Clinical narrative: 11/26 bad leg pain and headache  12/10 Bell?s palsy
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: At 5:34 pm 17 y/o pt. presented to the clinic with mother. Pt was registered and minor consent was signed by parent. Pt received Pfizer booster. Vaccine was administered by the patient?s sister. Although CDC has approved 17 y/o to get a Pfizer booster, this has not been implemented by our location which resulted in this being a medication error. Pt was observed 30 minutes. No signs or symptoms of any adverse reactions noted by the observation nurse.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pruritus, Swelling face
Clinical narrative: mother noticed pt c/o of itching everywhere, then at 6pm he began to have facial swelling and headache
Age: 32.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: FluMist Quadrivalent was given 1 day past expiration date. Vaccine expired on 12/07/2021. Was given on 12/08/2021.
Age: 19.0
Sex: F
Vaccine: COVID19, FLUC4
Symptoms: Asthenia, Loss of consciousness, Syncope
Clinical narrative: Patient came in for a Pfizer covid vaccine booster today and also received Flucelvax vaccine. The order was reviewed by precepting pharmacist, and vaccines were administered by intern. The patient was then sitting in the observation area when she started feeling weak and then started to lose consciousness. The mother quickly alerted the pharmacy staff and we rushed to assist patient. We paged code white over the intercom to alert management of the situation. We placed an ice pack behind patient's neck and the patient immediately regained consciousness. We also provided them with some snacks and cold water in case the patient was feeling low on sugar. We took a blood pressure reading and the patient had a BP of 84/48 which could explain the syncopy. Market manager was immediately. Reassessed patient after 30 minutes and the blood pressure is now 97/84. The patient is alert and oriented to everything happening. The mother will drive patient home and will alert the pharmacy if anything else occurs.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Fatigue, Functional gastrointestinal disorder, Headache, Nausea
Clinical narrative: Awakened by extreme nausea at 2am. Vomited violently until stomach empty. Cold sweat and intestinal discomfort. Digestive symptoms eased after stomach was empty. By 9am, headache and fatigue for 12 hours.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Awakened by extreme nausea at 2am. Vomited violently until stomach empty. Cold sweat and intestinal discomfort. Digestive symptoms eased after stomach was empty. By 9am, headache and fatigue for 12 hours.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Interchange of vaccine products
Clinical narrative: Client presented to receive Pfizer Vaccine  Client omitted receiving Astrazeneca prior to receiving Pfizer in Mexico. Client was given a booster four months earlier than when he was supposed to receive booster.  When client was sitting at vaccination table he was asked by Vaccinator if he had previously received a COVID vaccine. He denied. Vaccinated noticed Client?s mother had received a different vaccine in Mexico due to seeing her Mexico Vaccination card. He then preceded in asking the client a fourth time if he had received a different vaccine in a another Country. Client said he had forgotten that he had received Astrazeneca in Mexico. Client went to observation area and brought with him his vaccine documentation. Astrazeneca dose 1 6/9/21 and dose 2- 9/1/21.  RN was informed and spoke to client. Client was educated on waiting the six months to receive his booster and had received it too early. Per CDC guidelines, Client was informed by  RN ,Pfizer dose he received today will count as his booster and is considered fully vaccinated. Client verbalized understanding. Client was asked how he was feeling and client responded he was feeling fine. Client was recommended to speak to his primary care provider for any questions or non-life threatening symptoms might have. And to seek emergency care for any adverse reactions. Client verbalized understanding. Client left observation area at 1412 in a steady gait
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Aspartate aminotransferase increased, Bilirubin conjugated increased, Blood bilirubin increased, Blood culture, Blood fibrinogen increased
Clinical narrative: History of Present Illness:  This is a 68y.o. male with a history of CLL (follows with Dr.), HTN, BPH, hypothyroidism and obesity who presents to BFH-ED with complaint of shortness of breath and non-productive cough. Patient reports that these symptoms started on Monday, 11/15/21, and have been worsening over the week. He admits to significant dyspnea on exertion, headache and a decrease in appetite. Denies fevers, chills, body aches, lightheadedness/dizziness, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, worsening lower extremity edema. Patient is vaccinated against COVID.      ED course:  Vitals: BP 190/67, HR 98, RR 22, SpO2 86% on room air, Temp 101.7  Labs: Significant for COVID +, WBC 93.2, Lymphocytes 86.7, + smudge cells, AST 55, Total bilirubin 1.5, direct bilirubin 0.9, BNP 101. UA with 30 protein, 5 ketones, 3-5 RBC.  Imaging: CXR demonstrating multifocal pneumonia  Meds: Tylenol 1000 mg, and Albuterol given in the ED  Consultants: ID, Cardiology and Heme/Onc
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactate dehydrogenase increased, Brain natriuretic peptide increased, C-reactive protein increased, COVID-19, Chest X-ray abnormal
Clinical narrative: History of Present Illness:  This is a 68y.o. male with a history of CLL (follows with Dr.), HTN, BPH, hypothyroidism and obesity who presents to BFH-ED with complaint of shortness of breath and non-productive cough. Patient reports that these symptoms started on Monday, 11/15/21, and have been worsening over the week. He admits to significant dyspnea on exertion, headache and a decrease in appetite. Denies fevers, chills, body aches, lightheadedness/dizziness, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, worsening lower extremity edema. Patient is vaccinated against COVID.      ED course:  Vitals: BP 190/67, HR 98, RR 22, SpO2 86% on room air, Temp 101.7  Labs: Significant for COVID +, WBC 93.2, Lymphocytes 86.7, + smudge cells, AST 55, Total bilirubin 1.5, direct bilirubin 0.9, BNP 101. UA with 30 protein, 5 ketones, 3-5 RBC.  Imaging: CXR demonstrating multifocal pneumonia  Meds: Tylenol 1000 mg, and Albuterol given in the ED  Consultants: ID, Cardiology and Heme/Onc
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Decreased appetite, Dyspnoea, Dyspnoea exertional, Fibrin D dimer
Clinical narrative: History of Present Illness:  This is a 68y.o. male with a history of CLL (follows with Dr.), HTN, BPH, hypothyroidism and obesity who presents to BFH-ED with complaint of shortness of breath and non-productive cough. Patient reports that these symptoms started on Monday, 11/15/21, and have been worsening over the week. He admits to significant dyspnea on exertion, headache and a decrease in appetite. Denies fevers, chills, body aches, lightheadedness/dizziness, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, worsening lower extremity edema. Patient is vaccinated against COVID.      ED course:  Vitals: BP 190/67, HR 98, RR 22, SpO2 86% on room air, Temp 101.7  Labs: Significant for COVID +, WBC 93.2, Lymphocytes 86.7, + smudge cells, AST 55, Total bilirubin 1.5, direct bilirubin 0.9, BNP 101. UA with 30 protein, 5 ketones, 3-5 RBC.  Imaging: CXR demonstrating multifocal pneumonia  Meds: Tylenol 1000 mg, and Albuterol given in the ED  Consultants: ID, Cardiology and Heme/Onc